“…N eoplasms (at least in the short term) will be prioritized above inflammatory work, in part due to the backlog created by COVID‐19. A pps will be increasingly used by patients and medical professionals during the temporary pause in regular clinical activity,dermatologists will need to find a means of validating and working with these to make sure they conform to guidelines 3 , 4 and will help optimize health care.…”